필리핀 -
영어 -
FDA (Food And Drug Administration)
muconix 8mg capsule
le jumont pharma'l inc - bromhexine hydrochloride - capsule - 8mg
필리핀 -
영어 -
FDA (Food And Drug Administration)
neolecsin 100mg / ml powder for suspension (oral drops)
le jumont pharma'l inc - cefalexin (as monohydrate) - powder for suspension (oral drops) - 100mg / ml
필리핀 -
영어 -
FDA (Food And Drug Administration)
neolecsin 250mg / 5ml powder for suspension
le jumont pharma'l inc - cefalexin (as monohydrate) - powder for suspension - 250mg / 5ml
필리핀 -
영어 -
FDA (Food And Drug Administration)
clocsamed 500mg capsule
le jumont pharma'l inc - cloxacillin (as sodium) - capsule - 500mg
필리핀 -
영어 -
FDA (Food And Drug Administration)
isoforte 200mg + 20mg per 5ml syrup
le jumont pharma'l inc - isoniazid , pyridoxine hydrochloride - syrup - 200mg + 20mg per 5ml
필리핀 -
영어 -
FDA (Food And Drug Administration)
metaflam 500mg capsule
le jumont pharma'l inc - mefenamic acid - capsule - 500mg
필리핀 -
영어 -
FDA (Food And Drug Administration)
cuteplex [see reverse cpr] capsule
le jumont pharma'l inc - multivitamins , minerals - capsule - [see reverse cpr]
필리핀 -
영어 -
FDA (Food And Drug Administration)
trimocom 400mg + 80mg capsule
le jumont pharma'l inc - trimethoprim , sulfamethoxazole - capsule - 400mg + 80mg
필리핀 -
영어 -
FDA (Food And Drug Administration)
trimocom 200mg + 40mg / 5ml suspension
le jumont pharma'l inc - trimethoprim , sulfamethoxazole - suspension - 200mg + 40mg / 5ml
미국 -
영어 -
NLM (National Library of Medicine)
pantoprazole sodium tablet, delayed release
teva pharmaceuticals usa, inc. - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 20 mg - pantoprazole sodium delayed-release tablets are indicated for: pantoprazole sodium delayed-release tablets are indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (ee). for those adult patients who have not healed after 8 weeks of treatment, an additional 8 week course of pantoprazole sodium delayed-release tablets may be considered. safety of treatment beyond 8 weeks in pediatric patients has not been established. pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of ee and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd. controlled studies did not extend beyond 12 months. pantoprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including zollinger-ellison (ze) syndrome. - pantoprazole sodium delayed-release tablets are contraindic